Emergent BioSolutions SG&A Expense (Quarterly) Trends

Emergent BioSolutions Inc (EBS)

4.715 -0.04 (-0.95%) USD | NYSE | May 28, 16:00

4.715 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2006. Upgrade now.

Date	Value
March 31, 2024	84.70M
December 31, 2023	89.70M
September 30, 2023	86.00M
June 30, 2023	91.40M
March 31, 2023	101.30M
December 31, 2022	93.40M
September 30, 2022	81.80M
June 30, 2022	81.10M
March 31, 2022	84.80M
December 31, 2021	94.50M
September 30, 2021	82.10M
June 30, 2021	91.20M
March 31, 2021	80.90M
December 31, 2020	82.90M
September 30, 2020	75.50M
June 30, 2020	76.00M
March 31, 2020	69.70M
December 31, 2019	72.20M
September 30, 2019	65.00M
June 30, 2019	70.80M
March 31, 2019	65.40M
December 31, 2018	80.70M
September 30, 2018	42.10M
June 30, 2018	39.50M
March 31, 2018	40.00M

Date	Value
December 31, 2017	41.38M
September 30, 2017	34.50M
June 30, 2017	31.87M
March 31, 2017	35.15M
December 31, 2016	34.77M
September 30, 2016	40.69M
June 30, 2016	35.92M
March 31, 2016	31.71M
December 31, 2015	34.88M
September 30, 2015	25.80M
June 30, 2015	36.45M
March 31, 2015	34.49M
December 31, 2014	17.66M
September 30, 2014	30.29M
June 30, 2014	30.56M
March 31, 2014	30.09M
December 31, 2013	25.40M
September 30, 2013	21.96M
June 30, 2013	20.50M
March 31, 2013	20.03M
December 31, 2012	19.48M
September 30, 2012	19.16M
June 30, 2012	17.90M
March 31, 2012	19.49M
December 31, 2011	18.25M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

65.00M

Minimum

Sep 2019

101.30M

Maximum

Mar 2023

82.75M

Average

82.50M

Median

SG&A Expense (Quarterly) Benchmarks